Product Images Montelukast Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Montelukast Sodium NDC 62175-205 by Lannett Company, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - montelukast sodium tablets and chewable tablets 1

Figure 1 - montelukast sodium tablets and chewable tablets 1

This is a graph depicting the change in height (in cm) of individuals undergoing treatment with Montelukast Sodium 5mg, Beclomethasone 336mcg, or Placebo over 56 weeks. The x-axis shows the weeks on treatment ranging from -19 to 56, and the y-axis shows the change in height (in cm) ranging from -40 to +48.*

Chemical Structure - montelukast sodium tablets and chewable tablets 2

Chemical Structure - montelukast sodium tablets and chewable tablets 2

Figure 2 - montelukast sodium tablets and chewable tablets 3

Figure 2 - montelukast sodium tablets and chewable tablets 3

4 mg 90 count monte - montelukast sodium tablets and chewable tablets 4

4 mg 90 count monte - montelukast sodium tablets and chewable tablets 4

This is a description for a medication called "Montelukast" that comes in the form of chewable tablets. The medication is intended for pediatric patients between 2-5 years of age and is used to treat asthma and other breathing problems. The recommended dosage is 4.2 mg per day and it must be kept at controlled room temperature. The medication comes with a Medication Guide for each patient and is distributed by a company named Lannett. The text also includes instructions for storing the medication and a warning to keep it out of reach of children and pets.*

5 mg 90 count monte - montelukast sodium tablets and chewable tablets 5

5 mg 90 count monte - montelukast sodium tablets and chewable tablets 5

Eachtoblt antns 5.2 g is the name of a chewable tablet medication with NDC number 62175-205-46, containing Montelukast Sodium, equivalent to Montelukast. The medication is intended for pediatric patients aged 6-14 years with usual dosages accompanying Sodium. The tablets should be kept in a cool and dry place, stored at temperatures ranging from 15°C to 30°C (59-86°F). Patients should read the accompanying Medication Guide for instructions on usage and dosage. Lonnett Company, Inc. distributes the medication, and printed Medication Guides are available on their website.*

10 mg 90 count monte - montelukast sodium tablets and chewable tablets 6

10 mg 90 count monte - montelukast sodium tablets and chewable tablets 6

Each tablet of Montelukast Sodium contains 104 mg of Mortelukest Sadum equivalent to 1010 mg of Montelkest. Usual dosage information is provided in the accompanying dialo. It is important to keep this medicine and all drugs out of the reach of children. This medicine should be stored at temperatures ranging from 25°C (77°F) with permissible fluctuations to 15-30°C (59-86°F) [See USP Controlled Room Temperature] to protect it from moisture and light. The medicine is distributed by Lanett Company and comes in a protective packaging to retain its efficacy. For further guidance on the uses and dosage instructions, please obtain simplified guides either from the website jormett.corn/rred-quide/imortelukagt or print medication guides. 90 tablets are available in each package.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.